Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Enhancing Innate Immune Activation |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2009-06-02 |
| Study Made Public: | NA |
Title
Ho_Scheid_Infected_Patients
Description
CAVD 300 is an immunogenicity study to evaluate and characterize the neutralization activity in serum from a panel of HIV-infected individuals.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.